A Study of JNJ-77242113 in Participants With Moderate-to-severe Plaque Psoriasis
Public ClinicalTrials.gov record NCT05223868. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2b Multicenter, Randomized, Placebo Controlled, Dose-ranging Study to Evaluate the Efficacy and Safety of JNJ-77242113 for the Treatment of Moderate-to-Severe Plaque Psoriasis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Th purpose of the study is to evaluate the dose response of JNJ-77242113 in efficacy at Week 16 in participants with moderate-to-severe plaque psoriasis.
Study identification
- NCT ID
- NCT05223868
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 255 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 3, 2022 (Actual)
- Primary completion
- Dec 15, 2022 (Actual)
- Completion
- Dec 15, 2022 (Actual)
- Last update posted
- Feb 13, 2026
2022
United States locations
- U.S. sites
- 21
- U.S. states
- 15
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Medical Dermatology Specialists | Phoenix | Arizona | 85006 | — |
| Pacific Skin Institute | Sacramento | California | 95815 | — |
| Renstar Medical Research | Ocala | Florida | 34470 | — |
| Forcare Clinical Research Inc | Tampa | Florida | 33613 | — |
| Atlanta Dermatology, Vein & Research Center | Alpharetta | Georgia | 30022 | — |
| Arlington Dermatology | Rolling Meadows | Illinois | 60008 | — |
| Dawes Fretzin Clinical Research Group LLC | Indianapolis | Indiana | 46250 | — |
| Indiana Clinical Trial Center | Plainfield | Indiana | 46168 | — |
| DermAssociates, PC | Rockville | Maryland | 20850 | — |
| Hamzavi Dermatology | Fort Gratiot | Michigan | 48059 | — |
| Vivida Dermatology | Las Vegas | Nevada | 89119 | — |
| Windsor Dermatology, PC | East Windsor | New Jersey | 08520 | — |
| Oregon Dermatology and Research Center | Portland | Oregon | 97210 | — |
| University of Pittsburgh Department of Dermatology | Pittsburgh | Pennsylvania | 15213 | — |
| Modern Research Associates | Dallas | Texas | 75231 | — |
| Center for Clinical Studies | Houston | Texas | 77004 | — |
| Austin Institute for Clinical Research | Pflugerville | Texas | 78660 | — |
| Center for Clinical Studies | Webster | Texas | 77598 | — |
| Virginia Clinical Research | Norfolk | Virginia | 23502 | — |
| Dermatology Associates | Seattle | Washington | 98101 | — |
| Premier Clinical Research | Spokane | Washington | 99202 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 55 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05223868, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 13, 2026 · Synced Oct 30, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05223868 live on ClinicalTrials.gov.